B2B Software Technologies

B2B Software Technologies

31.29
-0.14
(-0.45%)
hide
Key Fundamentals
Add Ratio
Market Cap
36.24 Cr
EPS
2.27
PE Ratio
14.62
Dividend Yield
0.00 %
52 Week High
40.74
52 Week Low
22.50
PB Ratio
1.53
Debt to Equity
0.00
Forecast For
Actual

Company News

View All News
Caret
neutral
B2B Software Technologies Limited granted stock options to Executive Director Bala Subramanyam Vanapalli under the B2B ESOP Scheme 2024. The Nomination and Remuneration Committee approved the grant of 19,440 stock options for FY2024-25 and 5,371 stock options for FY2025-26, totaling 24,811 equity shares. The options are priced at Rs. 10 per option with 100% vesting after one year from the grant date. Vested options can be exercised within 30 days of vesting. The scheme is implemented through B2B ESOP Trust and complies with SEBI regulations. The grant was approved by shareholders at the 31st Annual General Meeting held on September 29, 2025.
positive
B2B Software Technologies Limited approved its unaudited financial results for the quarter and half year ended September 30, 2025. The company reported consolidated revenue of Rs 791.73 lakhs for the quarter compared to Rs 663.46 lakhs in the same period last year. Net profit for the quarter stood at Rs 63.29 lakhs versus Rs 60.69 lakhs in the previous year. The Board recommended a stock subdivision from Rs 10 per share to Rs 2 per share to enhance liquidity and attract smaller shareholders. Additionally, the company proposed extinguishing its existing ESOP scheme and implementing a new Restricted Stock Unit (RSU) scheme for eligible employees through a trust route. The Board also recommended exploring interim dividend payment possibilities at the next meeting. The company operates primarily in Information Technology services across India and USA segments, with India contributing Rs 423.19 lakhs and USA contributing Rs 343.11 lakhs to quarterly revenue.
neutral
B2B Software Technologies Limited has regularized Dr. Avinash Yaramati as a Non-Executive Director effective September 29, 2025, following approval at the company's 31st Annual General Meeting held via video conferencing. Dr. Yaramati was initially appointed as an Additional Director on July 12 and will be liable to retire by rotation. He brings medical expertise with an M.S. in General Surgery from Mamata Medical College and M.B.B.S. from Mahatma Gandhi Medical College & Research Institute. His experience includes serving as Registrar in Surgical Gastroenterology at Star Hospitals, Hyderabad, and academic roles at institutions including NIMS, Sri Manakula Vinayagar Medical College, and Gayatri Medical College, Visakhapatnam. Dr. Yaramati is not related to any other company directors.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
8,200.50
#1 71,271.80
30.69
#1 7,151.00
6.49
#1 2,380
-5.47
46.73
1,701.40
9,310.34
63.93
515.70
23.49
148
-39.14
41.89
579.70
7,687.83
16.54
4,067.90
2.46
507
-3.92
35.76
213.05
4,093.18
97.66
470.80
58.47
34
24.74
32.51
6,335.00
3,978.35
3,091.69
229.30
18.62
0
126.92
79.90
938.20
2,469.84
15.75
898.50
2.40
163
-20.54
29.39
614.20
2,294.81
266.19
596.90
12.64
-34
#1 231.25
55.89
307.25
1,663.59
#1 -2,225.00
300.30
-4.09
5
88.10
45.19
129.00
1,436.57
75.64
140.20
28.15
18
28.89
47.39
24.04
1,048.78
19.99
797.70
#1 58.75
44
35.09
35.92
Growth Rate
Revenue Growth
17.97 %
Net Income Growth
44.44 %
Cash Flow Change
14.77 %
ROE
27.22 %
ROCE
20.30 %
EBITDA Margin (Avg.)
11.93 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
3
3
3
3
3
4
4
4
3
3
5
4
5
5
6
5
4
5
6
6
5
5
5
7
5
7
6
8
7
8
Expenses
3
2
3
3
3
4
3
4
3
3
4
4
4
4
5
4
4
5
5
5
4
5
4
6
4
6
5
7
6
7
EBITDA
0
1
0
-0
0
1
1
0
1
1
1
0
1
1
1
1
0
1
1
1
0
0
1
1
1
1
1
1
1
1
Operating Profit %
-4 %
15 %
5 %
-19 %
1 %
10 %
9 %
-7 %
11 %
13 %
9 %
9 %
14 %
17 %
16 %
14 %
3 %
7 %
14 %
15 %
-1 %
2 %
16 %
7 %
17 %
5 %
7 %
5 %
4 %
9 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
0
0
-0
0
1
0
0
0
1
1
0
1
1
1
1
0
1
1
1
0
0
1
1
1
1
1
1
1
1
Tax
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
0
0
-0
0
0
0
-0
0
0
1
0
1
1
1
1
0
0
1
1
0
0
1
1
1
0
1
1
1
1
EPS in ₹
-0.03
0.14
0.17
-0.10
0.12
0.38
0.33
-0.04
0.29
0.38
0.60
0.36
0.56
0.57
0.64
0.54
0.12
0.36
0.70
0.88
0.10
0.30
0.73
0.47
0.97
0.26
0.56
0.49
0.56
0.55

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
7
8
9
11
12
13
15
18
20
23
25
Fixed Assets
0
0
0
0
0
0
0
0
0
0
0
Current Assets
6
7
8
10
11
13
14
17
19
22
24
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
1
2
3
6
7
7
10
11
13
14
17
Other Assets
5
6
6
5
5
6
5
7
7
9
9
Total Liabilities
7
8
9
11
12
13
15
18
20
23
25
Current Liabilities
1
2
2
2
2
2
2
2
2
3
3
Non Current Liabilities
0
0
0
0
0
1
0
0
0
0
0
Total Equity
5
7
8
9
9
11
13
16
18
20
23
Reserve & Surplus
-6
-5
-4
-3
-2
-1
1
4
7
8
11
Share Capital
12
12
12
12
12
12
12
12
12
12
12

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
1
0
-2
0
1
-1
1
0
2
-0
Investing Activities
-0
-2
-1
-3
-0
-0
-2
-1
-2
0
-2
Operating Activities
1
2
1
1
0
1
1
2
2
2
2
Financing Activities
0
0
0
0
0
0
0
0
0
0
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
73.42 %
73.09 %
69.99 %
69.80 %
69.79 %
69.80 %
69.80 %
69.80 %
69.80 %
69.80 %
69.80 %
69.36 %
68.27 %
64.34 %
60.06 %
59.83 %
59.83 %
62.66 %
62.45 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.22 %
21.61 %
24.72 %
24.56 %
24.73 %
24.75 %
22.95 %
22.92 %
22.86 %
22.89 %
22.89 %
23.42 %
24.48 %
28.09 %
31.43 %
31.76 %
31.78 %
33.48 %
33.76 %
Others
5.36 %
5.30 %
5.29 %
5.64 %
5.48 %
5.45 %
7.25 %
7.29 %
7.34 %
7.31 %
7.32 %
7.21 %
7.25 %
7.57 %
8.51 %
8.40 %
8.39 %
3.86 %
3.79 %
No of Share Holders
0
2,254
3,877
5,285
6,211
6,965
7,030
6,961
6,667
6,533
6,350
6,817
6,971
7,413
8,350
8,165
8,137
8,011
8,031

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
26 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2024 37.53 39.84
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 36.51 39.08
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 33.65 32.60
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 28.53 31.25
12 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Jul 2025 29.03 32.32
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 30.01 31.91
04 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Nov 2025 32.25 31.39

Announcements

News Paper Publication For Unaudited Financials (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th Sep 20258 days ago
Grant Of Stock Options To Executive Director Of The Company Under The B2B ESOP Scheme 2024Nov 04, 2025
Unaudited Financials (Standalone & Consolidated) 30Th Sep 2025Nov 04, 2025
Board Meeting Outcome for Unaudited Financial Reports For The Quarter And Six Months Ended 30Th Sep 2025Nov 04, 2025
Board Meeting Intimation for Meeting Scheduled To Be Held On Tuesday 04Th November 2025 At 4:00 P.M.Oct 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 30, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Closure of Trading WindowSep 26, 2025
Corrigendum To Notice Of The 31St Annual General MeetingSep 18, 2025
Reg. 34 (1) Annual Report.Sep 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Notice Of 31St Annual General Meeting Of The Company. Sep 07, 2025
Reg. 34 (1) Annual Report.Sep 07, 2025
Launch Of New Division Emerging TechnologiesAug 14, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sAug 13, 2025
Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 13, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderAug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August2025 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 12, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 16, 2025
Unaudited Financials News Paper PublicationJul 14, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 12, 2025
Unaudited Financial Results (Standalone & Consolidated) June 2025Jul 12, 2025
Board Meeting Outcome for Board Meeting Held On 12Th July2025Jul 12, 2025
Board Meeting Intimation for The Meeting Scheduled To Be Held On Saturday 12Th July 2025Jul 07, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJul 02, 2025
Closure of Trading WindowJun 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
News Paper Publication Of Financial Results 31St Mar 2025May 22, 2025
Grant Of Options Under Employee Stock Option Scheme ( " B2B ESOP Scheme 2024")May 19, 2025
Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31 March 2025May 19, 2025
Board Meeting Outcome for Audited Financials (Standalone & Consolidated) Quater And Year Ended March 3025May 19, 2025
Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended 31St March 2025May 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Closure of Trading WindowMar 26, 2025
Board Meeting Outcome for Outcomes Of Board Meeting For The Meeting Held On 25Th March 2025Mar 25, 2025
Integrated Filing (Financial)Feb 14, 2025
Grant Of Options Under Employee Stock Option Scheme 2024(B2B ESOP Scheme 2024)Feb 11, 2025
Results_Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months 31St Dec 2024Feb 11, 2025
Board Meeting Outcome for B2B Software Unaudited Financial Results For The Quarter And Nine Months Ended 31St Dec 2024Feb 11, 2025
Board Meeting Intimation for The Meeting Scheduled To Be Held On Tuesday 11Th February 2025 At 3:30 P.M.Feb 05, 2025
Intimation Of In-Principle Approval Received From BSE Ltd.Jan 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Closure of Trading WindowDec 27, 2024
News Paper Publication Of Financial Results 30Th Sep 2024Nov 15, 2024

Technical Indicators

RSI(14)
Neutral
46.06
ATR(14)
Less Volatile
1.31
STOCH(9,6)
Neutral
23.59
STOCH RSI(14)
Oversold
13.59
MACD(12,26)
Bearish
-0.05
ADX(14)
Weak Trend
13.55
UO(9)
Bearish
40.13
ROC(12)
Uptrend And Accelerating
0.13
WillR(14)
Oversold
-81.59